Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Celgene halts Revlimid trial after patient deaths

High mortality rate in trial involving elderly patients with rare leukaemia

Biogen Idec building

Biogen Idec signs brain research deal with Edinburgh University

Will identify potential treatments for multiple sclerosis and motor neurone disease

EC consults on orphan drug application guidelines

Also seeks input on the transfer of designations from one sponsor to another

- PMLiVE

Former Sanofi SVP to chair Idera

James Geraghty joins the firm with 20 years biotech experience from Genzyme

Merck’s Amelia Wall Warner joins Gentris

Will oversee US operations for pharmacogenomics company

- PMLiVE

Canadian Hospital launches mobile health app for service personnel

Intended to offer convenient support to operational stress injury sufferers

- PMLiVE

How to say a thousand words

There’s no need to make it as complex as ‘gamification’  – just get visual in how you reach your audiences

Boehringer trials digital diabetes programme

Will study effect of self-management technology on clinical care

- PMLiVE

PMEA 2013: Seven days until entry deadline

Programme recognises and commends pharma excellence, best practice and innovation

- PMLiVE

Non-amyloid therapies emerging for Alzheimer’s at AAIC

AAIC meeting hears new clinical data from Lundbeck, Baxter, Chiesi and Takeda

Novartis building

Novartis lifts 2013 guidance on delay to Diovan generics

Reveals scale of payments to former CEO Daniel Vasella

- PMLiVE

The CementBloc strengthens its payer strategy expertise

The CementBloc boosts its US payer strategy team and capabilities to help US clients navigate shifting payer landscape

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links